Suan, Rhex R.
HRN: 25-84-68 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/12/2024
11/18/2024
IV
50mg
Q24hours
Mastoid Abscess, Left
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes